CanSino Biologics Inc
688185
Company Profile
Business description
CanSino Biologics Inc is a China-based company engaged in the research and development, manufacturing, and commercialization of vaccine products for human use. Its products are Menhycia and Menphecia; Convidecia, Convidecia Air, and XBB.1.5 Variant; Ad5-EBOV; PCV13i; PBPV; and DTcP Infant. Its geographic areas are PRC and Overseas. It generates the majority of its revenue from the PRC.
Contact
185 South Avenue
401-420, 4th Floor, Biomedical Park
TEDA West District
Tianjin
CHNT: +86 4009222099
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2026
Employees
1,105
Stocks News & Analysis
stocks
Wide moat miner looking to shift focus
Investors cheered an increased dividend but still heavily dependent on iron ore.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,238.70 | 21.50 | 0.23% |
| CAC 40 | 8,404.90 | 43.44 | 0.52% |
| DAX 40 | 25,203.01 | 204.61 | 0.82% |
| Dow JONES (US) | 49,529.43 | 28.50 | 0.06% |
| FTSE 100 | 10,658.00 | 101.83 | 0.96% |
| HKSE | 26,705.94 | 138.82 | 0.52% |
| NASDAQ | 22,578.38 | 31.71 | 0.14% |
| Nikkei 225 | 57,143.84 | 577.35 | 1.02% |
| NZX 50 Index | 13,247.02 | 129.11 | 0.98% |
| S&P 500 | 6,839.81 | 3.64 | 0.05% |
| S&P/ASX 200 | 9,007.00 | 12.80 | 0.14% |
| SSE Composite Index | 4,082.07 | 51.95 | -1.26% |